Concepedia

Vincent J. Colandrea

VJ

Statistics

Publications

15

Citations

616

H-Index

14

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Rutgers, The State University of New Jersey

Vincent J. Colandrea is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1994–2018

15

Publications

15

Improved synthesis of aryl 1,1-dimethylpropargyl ethers

Jollie D. Godfrey, Richard H. Mueller, Thomas C. Sedergran et al. · Tetrahedron Letters · 1994 · 127 citations

, , +5

1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1–3 (HIF PHD1–3) for the Treatment of Anemia

Petr Váchal, Shouwu Miao, Joan M. Pierce et al. · Journal of Medicinal Chemistry · 2012 · 66 citations · Full text

, , +17

Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach

Jonathan E. Wilson, Ravi Kurukulasuriya, Mikhail Reibarkh et al. · ACS Medicinal Chemistry Letters · 2016 · 53 citations · Full text

, , +13

Synthesis of the Mitomycin and FR900482 Ring Systems via Dimethyldioxirane Oxidation

Vincent J. Colandrea, Shanthi Rajaraman, Leslie S. Jimenez · Organic Letters · 2003 · 46 citations

, , +11

Human β3 andrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

Elizabeth M. Naylor, Emma R. Parmee, Vincent J. Colandrea et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 46 citations · Full text

, , +7

1–5 of 15